FDA Approves Drug for Thrombocytopenia in Adults with Chronic Liver Disease
On May 21, 2018, the Food and Drug Administration approved avatrombopag (Doptelet, AkaRx Inc.) for thrombocytopenia in adults with chronic liver disease scheduled to undergo a procedure.
In Person Meeting & NetworkingMay 6, 2026 at 8:00 AM EDT560 King Street, Charleston, SC, USAHyatt Place + Hyatt House Charleston - Historic District, Charleston
In Person Conference & ConventionApril 15, 2026 at 5:00 PM CDTPark Pl Blvd, St. Louis Park, MN, USADoubleTree by Hilton Hotel Minneapolis - Park Place, St. Louis Park
